Medtronic Non-Controlling Interests increased by 3.4% to $211.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.5%, from $228.00M to $211.00M. Over 4 years (FY 2021 to FY 2025), Non-Controlling Interests shows an upward trend with a 7.5% CAGR.
Changes reflect the ownership structure of consolidated entities and the performance of those specific subsidiaries.
Noncontrolling interests represent the portion of equity in a subsidiary that is not attributable, directly or indirectl...
Common in companies with complex organizational structures or joint ventures.
noncontrolling_interests| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $178.00M | $168.00M | $171.00M | $171.00M | $170.00M | $177.00M | $177.00M | $182.00M | $188.00M | $187.00M | $204.00M | $206.00M | $213.00M | $222.00M | $228.00M | $232.00M | $240.00M | $204.00M | $211.00M |
| QoQ Change | — | -5.6% | +1.8% | +0.0% | -0.6% | +4.1% | +0.0% | +2.8% | +3.3% | -0.5% | +9.1% | +1.0% | +3.4% | +4.2% | +2.7% | +1.8% | +3.4% | -15.0% | +3.4% |
| YoY Change | — | — | — | — | -4.5% | +5.4% | +3.5% | +6.4% | +10.6% | +5.6% | +15.3% | +13.2% | +13.3% | +18.7% | +11.8% | +12.6% | +12.7% | -8.1% | -7.5% |